Lululemon Athletica LULU
Consumer Cyclical · Apparel - Retail · Synthos Deep Dive · 2026-07-03
The Overview
Lululemon makes premium yoga and athletic clothing — the $100+ leggings you've seen at the mall. It's a genuinely good, profitable company that owes almost nothing to the bank. But its home market (the US and Canada) has stopped growing: shoppers there are buying less, competitors like Alo and Vuori are stealing attention, and the company just told Wall Street that this year's sales and profit will be lower than last year's. That's why the stock has fallen by half in a year.
Because it fell so far, the stock is now cheap — you're paying about $9 for every $1 of yearly profit, which is bargain-bin pricing for a brand this strong. The risk is that the profit itself keeps shrinking, so "cheap" gets cheaper.
Our verdict is Watch — not "buy," not "avoid." It's a coin worth keeping in view, but we want to see sales stop falling before betting on a comeback.
Here's what our three scores mean in everyday terms:
- Downside Risk 6/10 (a bit above middle). The balance sheet is safe and the price is low, but the earnings are still sliding and the chart is broken, so it can keep drifting down.
- Growth Quality 4/10 (below average). Right now growth is going backwards at home, even though China is booming.
- Exponential Potential 3/10 (low). This is a shrinking-then-maybe-stabilizing story, not a fast-growth rocket.
The one big worry: the brand may be genuinely losing its cool factor in the US — and if that's true, no amount of cost-cutting fixes it.
Putting a number on it: our fair-value estimate is $138 against a current price of $120.81 — real upside if our numbers are right.
Our summary metrics
Net-cash balance sheet & 9× trailing cap the downside, but negative earnings revisions and a broken-momentum chart cut the other way.
Guidance now points to flat-to-down FY26 revenue and a ~17% EPS decline; margins rolling over as Americas comps go negative.
Growth is decelerating, not accelerating — the only exponential left is China/international, not the whole company.
What does “fair value” mean?
Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.
The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.
What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Exponential Potential
Growth is decelerating, not accelerating — the only exponential left is China/international, not the whole company.
What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.
Deeper analysis
Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.
Reference table
| Street consensus | $144 (high $250 / low $88; median $115; 29 Buy · 38 Hold · 4 Sell → Hold) — context, not our anchor |
| Valuation | 8.9× trailing EPS · ~10.7× FY26E guide · EV/EBITDA 5.1× · EV/S 1.3× · P/S 1.2× — statistically cheap |
| Technicals | Downtrend — $118, −52% off the 52-wk high, below 50- & 200-DMA, RSI 46, −52% 12-mo (SPY +21%) |
| Conviction | Low — 0 net-bullish voices; the single signed KB voice is bearish (Compound & Friends, conviction 65) |
| Position sizing | Watch / starter only, ≤1–2% if a value sleeve — sized for a turnaround that has not yet turned |
What the experts actually said 3 traceable claims on LULU · showing the highest-conviction voices
“Value portfolio buys companies that operationally tripped—currently holds Netflix and Lululemon (past examples: Starbucks, Nike).”
“Lost brand mojo to Aloe/Vori/Athleta; no denim-cycle tailwind since it sells no denim; nothing obvious turns it around.”
Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.
Price & moving averages 12 months · 50 & 200-day averages · 52-week range
Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.
Data summary: last close $120.81, 3% above the 50-day average ($118), 22% below the 200-day average ($154) — a mixed trend. 44% below the 52-week high of $216, 15% above the 52-week low of $105.
Bollinger Bands 20-day average ± 2 standard deviations
The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.
Data summary: price $120.81 is currently inside the band (band $113–$129).
RSI (14) momentum gauge · 0–100
Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 52.
MACD 12 / 26 / 9 · trend & momentum
The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.
Data summary: MACD is currently below its signal line by 0.40, negative momentum.
Relative performance vs S&P 500 & its sector (XLY (sector)), set to 100 a year ago
Solid = LULU · dashed = S&P 500 · dotted = XLY (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.
Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate
Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.
Key stats an RIA wants
1. What it is
Lululemon Athletica (NASDAQ: LULU) is a Vancouver-based premium athletic-apparel brand — leggings, tops, jackets, shorts, and a growing footwear and accessories line — sold through ~816 company-operated stores and a large direct-to-consumer e-commerce channel. Founded 1998, IPO 2007. Fiscal year ends late January/early February; FY2025 ended 2026-02-01. The company is currently run by interim co-CEOs (Meghan Frank, also CFO, and André Maestrini) — a leadership-transition overhang worth flagging up front.
Revenue mix (FY2025, from filings):
- By product: Women's $7.00B (63%) · Men's $2.66B (24%) · Other (accessories/footwear) $1.44B (13%). Women's is the franchise; men's and footwear are the stated growth vectors.
- By geography: United States $6.33B (57%) · China $3.71B (33%) · Canada $1.42B · rest-of-world $1.30B · Mexico $0.10B. The story in one line: the US is now barely more than half of revenue and shrinking, while China more than doubled year-on-year ($1.54B → $3.71B) and is the single biggest reason the top line still grew at all.
This is the crux of the entire thesis: a decelerating, arguably-eroding home market offset by a genuinely exponential China/international ramp. Whether the second can outrun the first is the whole question.
2. The expert thesis — (thin coverage, and it's bearish)
Honest disclosure: the Synthos KB has only 2 traceable claims on LULU, 0 net-bullish voices, and the single signed voice is bearish. There is no expert-conviction tailwind here. This verdict is fundamentals- and quant-driven, and the one expert we do have argues against owning it.
- Compound & Friends (
compound_and_friends-TLMfVxCP5-U:88b124c13b, bearish, conviction 65, skill 1.0, dated 2026-01-02): Lululemon has "lost brand mojo to Alo/Vuori/Athleta," there's "no denim-cycle tailwind since it sells no denim," and "nothing obvious turns it around." This is a brand-erosion / no-catalyst thesis, and — uncomfortably — the FY26 guidance cut and negative Americas comps that landed after this claim are consistent with it.
What this means for the call. With no bullish expert to lean on, we are underwriting LULU purely on the numbers and the setup. The bear voice we do have has, so far, been directionally right. We do not manufacture conviction we don't have: breadth 0, net conviction −65, and the verdict reflects that honesty — Watch, not Buy.
3. Synthos scores & the Bull / Base / Bear cases
The one-glance judgment — three scores, 0–10, each anchored to real metrics:
| Score | 0–10 | The read |
|---|---|---|
| Downside Risk (lower = safer) | 6 · Moderate-High | Net-cash balance sheet (net debt −$9M), 9× trailing EPS and 5.1× EV/EBITDA cap the fundamental downside — but negative EPS revisions, a −52% 12-mo chart below both moving averages, and consumer cyclicality push risk up, not down. Cheap ≠ safe when estimates are still falling. |
| Growth Quality | 4 · Below Average | Guidance now points to flat-to-down FY26 revenue and EPS falling from $13.27 to ~$11.05 (−17%); Q1 operating margin fell 730bps to 11.2%. ROE (31%) and ROIC (20%) are still elite, which keeps this off the floor — but the trend is deteriorating. |
| Exponential Potential | 3 · Low | Company-wide growth is decelerating. The only accelerating piece is China/international (Q1 international +22%). A single fast segment inside a flat whole is not an exponential. |
The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities; the cases bound the range and the scores summarize them. All EPS figures are estimates.
| Case | Key assumptions | Fair value |
|---|---|---|
| Bull | Americas comps inflect back to positive by FY27; China/international keep compounding double-digit; margins stabilize; brand-repositioning works. FY27E EPS recovers to ~$13.5 and the market re-rates a growth-restored LULU to ~16×. | ~$216 (+82%) |
| Base (our anchor) | Americas stay soft but stabilize; international carries a low-single-digit total; margins bottom near guidance. FY27E EPS ~$11.5; a low-growth-but-clean-balance-sheet brand earns a ~12× multiple. | ~$138 (+17%) |
| Bear | Brand erosion is structural (the Compound & Friends thesis); Americas comps stay negative, promotions deepen, margins compress further. FY27E EPS ~$9.5; multiple stays distressed at ~9×. | ~$86 (−27%) |
Synthos fair value = the base case, ~$138 (+17%), with the full $86–$216 span as the honest range. Our base sits essentially on the Street's $144 consensus (and above the $115 median), while our bear ($86) roughly matches the Street's $88 low. The width of this range — a near-triple from bear to bull — is the real message: this is a binary turnaround bet dressed up as a cheap stock. This is a tracked call.
4. Exponential Potential
Synthos separates compounders (durable high returns on capital) from exponentials (accelerating, multi-baggers-from-here). LULU is neither right now — it's a former compounder in a growth stall:
- Forward growth: consensus revenue CAGR FY25→FY30E is only ~3.8% ($11.10B → $12.90B est); management's own FY26 guide is flat-to-down 1%. This is not a growth company at the consolidated level today.
- Acceleration (2nd derivative) is negative: revenue growth ran +18.6% (FY23) → +10.1% (FY24) → +4.9% (FY25) → ~0% (FY26E guide). The deceleration is the whole problem. EPS is now guided down (~$13.27 → ~$11.05).
- The one genuine accelerant — China/international: China revenue roughly doubled YoY ($1.54B → $3.71B) and Q1 international revenue grew +22%. If LULU were only its international business it would score 8+. It isn't — international is ~43% of revenue and can't yet offset a shrinking Americas.
- Room to run: at $13.4B market cap the stock is small enough that a successful turnaround could re-rate hard (hence the +82% bull case). But "room to run" only pays if growth returns; today the reinvestment is going into a business whose home-market returns are declining.
Exponential Potential: Low (3/10). Per our flagship philosophy we pick forward next-exponentials, not trailing compounders in decline. LULU is the latter with a call option on the former (China). Own it, if at all, for the value/mean-reversion, not for exponential growth.
5. Financials (real numbers — FMP annual/quarterly)
- Revenue: FY25 $11.10B, +4.9% (FY24 $10.59B, +10.1% on FY23 $9.62B). Growth has halved and halved again.
- The quarter that matters — Q1 FY26 (ended 2026-05-03): revenue $2.47B, +4% (but only +2% constant-currency, and comps +1% / −2% cc). Americas net revenue −3%; international +22%. Operating income −37% to $277M; operating margin −730bps to 11.2%; diluted EPS $1.69 vs $2.60 a year ago. This print, plus the guidance cut, is the fulcrum of the whole note.
- Margins: gross 56.6% TTM (Q1 gross margin fell 410bps to 54.2% as the brand leaned on promotion); operating ~18% TTM but trending down; net 13.0% TTM. Still healthy in absolute terms — the issue is direction.
- Earnings: FY25 net income $1.58B, EPS $13.27 — but down from FY24's $1.81B / $14.67 as buybacks masked a net-income decline. Q1 FY26 net income $195M.
- Cash flow: FY25 operating CF $1.60B, capex −$681M, FCF $922M (FCF yield ~7%). Note FCF fell from $1.58B (FY24) as working capital and capex weighed — another deterioration tell.
- Balance sheet — the strength: cash $1.81B, total debt $1.80B (almost entirely capitalized leases), net debt −$9M (net cash), net-debt/EBITDA 0.24×, current ratio 2.2×. This is the reason the stock isn't cheaper: there is no solvency risk and management is buying back stock ($1.18B repurchased in FY25; $358M in Q1 FY26).
6. Valuation — cheap, or a value trap?
On the multiples, LULU is statistically cheap: 8.9× trailing EPS, ~10.7× the FY26 guidance midpoint, EV/EBITDA 5.1×, EV/Sales 1.3×, P/S 1.2×, FCF yield ~7%, P/B 2.8×. For a brand with 56% gross margins, 31% ROE and net cash, those are the multiples of a business the market has decided is structurally impaired, not merely cyclically soft.
The bull case is pure mean-reversion: a brand this profitable rarely stays at 9× if earnings simply stop falling. The bear case is the value-trap: at flat-to-down revenue and compressing margins, "cheap" is a fair price for a fading brand, and 9× can persist or fall further (the stock already de-rated from ~30× to 9× as the market re-priced the growth). Reverse read: at $118 the market is pricing roughly zero long-term growth and no margin recovery. That's a low bar — which is exactly why the risk/reward is interesting but not yet actionable: you need one quarter of stabilizing comps to know whether 9× is a floor or a landing. Street targets (context): consensus $144, high $250, low $88, median $115 — note the median sits below the mean, i.e. the average is dragged up by a few optimistic holdouts. Not our anchor.
7. Technicals (from the tech block)
- Trend: down. $118.43 sits below the 50-DMA ($125) and far below the 200-DMA ($165); the 50 is below the 200 (death-cross posture). MACD −3.3 (negative).
- Location: −52% off the 52-week high ($247.68), only +12% off the 52-week low ($105.43) — near the bottom of a brutal range, with a max drawdown from peak of −77%.
- Momentum: RSI(14) 46 — neutral, neither oversold-bounce nor overbought; no technical "falling knife caught" signal yet.
- Relative strength (the tell, and it's ugly): LULU −51.7% 12-mo vs SPY +20.6% and QQQ +30.3%; −25% 3-mo vs SPY +14% / QQQ +22%. Persistent, severe underperformance of both the market and tech — the chart has not confirmed any bottom.
- Read: technicals do not support stepping in yet. A base needs to form (reclaim the 50-DMA, MACD cross positive) before the chart corroborates a turnaround. This is a "wait for the price action to agree" name.
8. Moat & competitive position
Lululemon's moat is a premium brand with genuine pricing power (56% gross margin), a loyal community, a vertically integrated DTC model, and best-in-class returns on capital (ROE 31%, ROIC 20%). Those are real and are why the balance sheet and cash flows stay strong even in a stall. But the moat is eroding at the edges in its core market: the Compound & Friends thesis (compound_and_friends-TLMfVxCP5-U:88b124c13b) is precisely that Alo, Vuori and a revived Athleta are peeling off the brand's cachet, and negative Americas comps are the quantitative echo of that. A brand moat is only as durable as its cultural relevance — and that is the single hardest thing to underwrite.
Peer set (FMP-supplied, mostly smaller US apparel retailers): On Holding (ONON, $12.3B — the most relevant, a fast-growing premium athletic peer taking share), Burlington ($19.7B), Urban Outfitters ($6.1B), Gap ($6.9B), Abercrombie & Fitch ($4.1B), Boot Barn ($4.8B), American Eagle ($2.8B), Buckle ($2.2B), Carter's ($1.5B), Guess ($0.9B). LULU is the largest and highest-margin of the group, but ONON is the one growing into the premium-athletic space LULU is ceding.
9. Management, capital allocation & guidance
- Leadership: currently run by interim co-CEOs (Meghan Frank/CFO and André Maestrini) — a governance/continuity overhang. A permanent-CEO decision is itself a catalyst and a risk.
- Capital allocation: aggressive buybacks — $1.18B repurchased in FY25, $358M in Q1 FY26 — funded by strong FCF and net cash, no dividend. Buying back stock at 9× while net-cash is shareholder-friendly if the business stabilizes; it's value-destructive if earnings keep falling. Capex ~$681M/yr into stores and international.
- Insider activity: the only recent Form 4s (filings 2026-06-29) are routine director equity awards (1,606 shares each, price $0) — not open-market buying or selling. No signal either way.
- Management's own guidance (half-weighted — they talk their book): the SEC 8-K earnings release (filed 2026-06-04, Q1 FY26) is a real earnings release and it is a downgrade. In management's own words, they "have been navigating headwinds that have led us to adjust our outlook for the full year." Specifics:
- Q2 FY26: net revenue $2.450–2.475B (−3% to −2%); diluted EPS $1.76–1.81; ~30% tax rate.
- Full-year FY26: net revenue $11.000–11.150B (−1% to 0%); diluted EPS $10.95–11.15; ~30% tax rate.
- Guidance explicitly excludes potential IEEPA tariff refunds and future buybacks — so there is some conservatism baked in, but the headline is unambiguous: revenue flat-to-down and EPS down double digits vs FY25's $13.27. Treat this as management's self-interested but freshly-cut view; the fact that they cut is more informative than the exact numbers.
10. Catalysts & what to watch
- Next earnings: 2026-09-03 (Q2 FY26; Street EPS $1.79, revenue ~$2.46B — consistent with management's −3%/−2% guide). The key line: Americas comparable sales — the single number that decides bull vs bear.
- China/international trajectory: can +20%-ish international growth continue and expand as a share of revenue? This is the bull's engine.
- Gross margin & promotions: is the 410bps Q1 gross-margin decline a one-off or the start of structural discounting?
- Permanent CEO announcement: leadership clarity (or a strategic reset) is a discrete catalyst.
- Guidance revisions: another cut would confirm the value-trap; a raise or reaffirm-with-stabilizing-comps would validate the base/bull.
Thesis tripwires (what would change the call): Upgrade to Watch→Buy if Americas comps turn positive or management reaffirms/raises guidance for two quarters. Downgrade toward Avoid if there's a third consecutive guidance cut, Americas comps worsen, or gross margin keeps falling.
11. Key risks
- Brand erosion in the Americas (structural, the big one): the Compound & Friends thesis (
compound_and_friends-TLMfVxCP5-U:88b124c13b) — losing cultural relevance to Alo/Vuori/Athleta. If true, this is not fixable by cost cuts, and the bear case governs. - Value trap / continued de-rating: cheap on a shrinking earnings base can get cheaper; 9× is not a guaranteed floor.
- China concentration risk (double-edged): 33% of revenue and the only growth engine — but that means outsized exposure to a China consumer slowdown, FX, or geopolitical/tariff shocks.
- Margin compression: promotions to move product are already visible (gross margin −410bps in Q1); a discounting spiral would hit the earnings base further.
- Leadership vacuum: interim co-CEOs; strategy and permanent leadership are unresolved.
- Cyclicality: premium discretionary apparel is exposed to a consumer downturn (beta 0.86 understates the operational cyclicality).
12. Verdict, position sizing & monitoring
Watch. LULU is a genuinely high-quality, net-cash, cash-generative brand that has fallen to a distressed 9× earnings — and that valuation, plus a doubling China business, is why this is a Watch and not an Avoid. But three things keep it out of the Buy column today: (1) the only expert voice we have is bearish and has so far been right; (2) management just cut guidance to flat-to-down revenue and lower EPS; and (3) the core Americas business is shrinking, which is a demand/brand problem, not a working-capital glitch. Cheap plus falling estimates plus a broken chart is the textbook setup you watch, not chase.
- Sizing: Watch / ≤1–2% starter only if you run a value sleeve and want a toehold ahead of a possible inflection. This is a turnaround that has not yet turned; size for the possibility it doesn't.
- Monitoring: the whole call pivots on Americas comparable sales at the 2026-09-03 print. Two quarters of stabilizing comps or a guidance reaffirm → upgrade to Buy — Tactical. Another cut → downgrade toward Avoid. Formal re-score each earnings print. Logged as a tracked Synthos call as of 2026-07-03 at $118.43.
- Single biggest risk: brand erosion in the Americas turning out to be structural rather than cyclical.
Provenance & disclosures
- Traceability: 2 KB claims, breadth 0 net-bullish, net conviction −65 (one bearish voice, Compound & Friends, skill 1.0, dated 2026-01-02) — the single cited
claim_idis real and reconciled. There is no expert-conviction support for a bullish case; this note is explicitly fundamentals- and quant-driven, and we label it as such. Fabricated conviction is structurally impossible (claim-ID reconciliation). - Data as-of: fundamentals 2026-05-03 (Q1 FY26) · estimates & prices 2026-07-02/03 · expert claims through 2026-01-02. Forward figures are analyst consensus or management guidance (FMP/SEC), labeled as estimates.
- Management caveat: the FY26 guidance in §9 is management's own book, half-weighted by design — notable here because it is a downgrade (a cut is more informative than the precise figures).
- Not investment advice. Independent research, educational and informational only, never personalized. Hypothetical/forward figures are labeled; the only performance numbers Synthos will headline are the live, real-money Flagship's.
- Version: 2026-07-03. Prior versions available via the deep-dive version dropdown ("based on the info at the time").